News

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...
New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...
A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...
Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...